Paragon Care WKN: A0Q4D2 ISIN: AU000000PGC4 Kürzel: PXS Branche: Gesundheit, Medizinischer, Vertrieb
Kursdetails
Geld (bid) | 0,1720 (2.882) |
---|---|
Brief (ask/offer) | 0,1990 (2.882) |
Spread | 13,5678 |
Geh. Stück | 0 |
Eröffnung | 0,1735 |
Vortag | 0,1735 |
Tageshoch | 0,1855 |
Tagestief | 0,1735 |
52W Hoch | 0,1860 |
52W Tief | 0,0910 |
Tagesvolumen
in EUR gehandelt | 0 Stk |
---|---|
in AUD gehandelt | 0 Stk |
Gesamt | 0 Stk |
Partner-News
Anzeige7:01 Uhr • Partner • Societe Generale
Gestern 18:00 Uhr • Partner • Societe Generale
Gestern 16:46 Uhr • Partner • Societe Generale
Gestern 16:00 Uhr • Partner • BNP Paribas
Gestern 15:00 Uhr • Partner • HSBC
Aktien-News
11:53 Uhr • Meldungen • EQS News
11:38 Uhr • Partner • MediaFeed
11:30 Uhr • Meldungen • EQS News
11:30 Uhr • Meldungen • EQS News
Geld/Brief Kurse
Neu ladenBörse | Geld | Vol. | Brief | Vol. | Zeit | Vol. ges. | Kurs |
---|---|---|---|---|---|---|---|
L&S Exchange | 0,1720 | 2.882 Stk | 0,1990 | 2.882 Stk | 1711663155 28. Mar | 0,1855 EUR | |
Frankfurt | 0,1720 | 12.281 Stk | 0,2000 | 20.000 Stk | 1711609546 28. Mar | 0,1720 EUR | |
Tradegate | 0,1720 | 5.000 Stk | 0,1990 | 5.000 Stk | 1711661181 28. Mar | 0,1860 EUR | |
Lang & Schwarz | 0,1720 | 2.882 Stk | 0,1990 | 2.882 Stk | 1711663126 28. Mar | 0,1855 EUR | |
TTMzero RT | 1711630267 28. Mar | 0,1855 EUR | |||||
Stuttgart | 0,1720 | 4.444 Stk | 0,1990 | 4.444 Stk | 1711618475 28. Mar | 0,1710 EUR | |
Sydney | 1711429838 26. Mar | 0,2800 AUD | ges. 0 Stk |
Börsennotierung
Marktkapitalisierung in EUR |
---|
122,3 Mio. |
Anzahl der Aktien |
659,3 Mio. |
Termine
28.08.2024 | Quartalsmitteilung |
---|---|
02/25 | Quartalsmitteilung |
Grundlegende Daten zur PARAGON CARE Aktie
Finanzdaten | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e |
---|---|---|---|---|---|---|---|
KUV | 0,19 | 0,36 | 0,71 | 0,47 | - | - | - |
Ergebnis je Aktie (bereinigt) | -0,30 | 0,02 | 0,01 | 0,02 | 0,01 | - | - |
Cashflow | 5,3 Mio. | 27,5 Mio. | 19,0 Mio. | 17,7 Mio. | - | - | - |
Eigenkapitalquote | 38,43 % | 41,63 % | 53,79 % | 54,14 % | - | - | - |
Verschuldungsgrad | 160,21 | 140,23 | 83,25 | 80,94 | - | - | - |
EBIT | 4,1 Mio. | 14,0 Mio. | 21,3 Mio. | 26,4 Mio. | - | - | - |
Fundamentaldaten | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e |
KCV | 8,50 | 3,05 | 8,51 | 7,00 | - | - | - |
Dividendenrendite | 2,53 % | 4,32 % | 4,02 % | 4,07 % | - | - | - |
Kurs-Gewinn-Verhältnis (KGV) | -0,57 | 12,21 | 25,52 | 10,50 | 26,03 | - | - |
Dividende je Aktie | 0,011 | 0,016 | 0,012 | 0,01 | - | - | - |
Bilanzdaten | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e |
Umsatzerlöse | 231,7 Mio. | 235,8 Mio. | 237,6 Mio. | 307,6 Mio. | - | - | - |
Ergebnis vor Steuern | -77,2 Mio. | 12,3 Mio. | 9,9 Mio. | 20,9 Mio. | - | - | - |
Steuern | 66.000 | 4,1 Mio. | 3,3 Mio. | 10,1 Mio. | - | - | - |
Ausschüttungssumme | 7,9 Mio. | 7,9 Mio. | 7,9 Mio. | 7,9 Mio. | - | - | - |
Info PARAGON CARE Aktie
Paragon Care
Paragon Care Limited supplies durable medical equipment, medical devices, and consumable medical products to health and aged care markets in Australia, New Zealand, and internationally. The company offers clinical solutions for anaesthetists, intensivists, cardiac, vascular, and pain management; designs, manufactures, and distributes reagent red blood cells, monoclonal blood grouping reagents, and ancillary products for immunohaematology laboratories; and eye care products, such as ophthalmology and optometry, neonatal vision screening, and procedural kits. It also provides neonatal and paediatric assessment and treatment, including newborn hearing and vision screening, jaundice management, targeted temperature management, cerebral function monitoring, and seizure detection, as well as pain management and enteral feeding solutions; surgical products for hip and knee arthroplasty, infection prevention, pain management, biologics, and the operating room; and equipment repair and maintenance services. In addition, the company offers sterilisable transducers for surgical procedures such as neurology, hepatobiliary, renal, colorectal, vascular, laparoscopic, and robotic procedures; ultrasound systems, shockwave therapy, lasers, and accessories for infection control; and veterinary products, including point-of-care diagnostics, therapeutic lasers, oncology delivery products, centrifuges, autoclaves, IV lines and fluid therapy products, wearable CRI systems, and IT Solutions. Further, it provides telephony, nurse call, access control, CCTV, cordless, and Wi-Fi products. The company was formerly known as Citrofresh International Limited and changed its name to Paragon Care Limited in June 2008. The company was incorporated in 1994 and is based in Mt Waverley, Australia.